Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2008-12-31Clinical Trial Update: Diagnostic and Prognostic Biomarkers in Parkinson Disease
An update on a clinical trial from the Parkinson Study Group examining diagnostic and prognostic biomarkers for Parkinson disease, with rela…
-
CLINICAL_TRIALS trial_result · 2008-12-23Clinical Trial Update: Study of the Effect of SR57667B on 18F-Dopa PET Imaging in Patients With Parkinson's Disease [Phase 2]
Phase 2 study evaluating SR57667B on 18F-Dopa PET imaging in patients with Parkinson disease; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2008-12-23Clinical Trial Update: Study of the Effect of SR57667B on the Progression of Symptoms in Patients With Parkinson's Disease [Phase 2]
A Phase 2 trial evaluating SR57667B for progression of symptoms in Parkinson disease has completed. The snippet does not provide trial resul…
-
CLINICAL_TRIALS research · 2008-11-13Clinical Trial Update: Mechanisms of Fronto-Subcortical Dysfunction: Comparing PD and OCD
This clinical trial update discusses research into the neural mechanisms of fronto-subcortical dysfunction in Parkinson's disease and obsess…
-
CLINICAL_TRIALS trial_result · 2008-11-07Clinical Trial Update: 2 Year Study to Evaluate the Effects of GPI 1485 on [123I]b-CIT/SPECTScanning and Clinical Efficacy in Patients With PD [Phase 2]
A Phase 2 study evaluating GPI-1485 in Parkinson's disease, including imaging with [123I]β-CIT/SPECT, has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2008-10-28FDA Approved: CARBIDOPA AND LEVODOPA — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' original application for a generic carbidopa and levodopa combination tablet. The drug is indica…
-
CLINICAL_TRIALS trial_result · 2008-10-08Clinical Trial Update: Impact of Deep Brain Stimulation of Subthalamic Nucleus on the Hepatic Glucose Production in Parkinson's Disease [NA]
This clinical trial update reports that the study evaluating deep brain stimulation of the subthalamic nucleus and its effects on hepatic gl…
-
CLINICAL_TRIALS trial_result · 2008-10-07Clinical Trial Update: Botulinum Toxin for Treatment of Seborrhic Dermatitis in Parkinsonian Patients [Phase 1]
Phase 1 trial investigating botulinum toxin for seborrheic dermatitis in Parkinsonian patients; current status is unknown.
-
FDA approval · 2008-10-01FDA Approved: BROMOCRIPTINE MESYLATE — Original Application (Padagis US LLC)
FDA approved Padagis US LLC's original generic application for bromocriptine mesylate. This approval provides a generic version of bromocrip…
-
CLINICAL_TRIALS trial_result · 2008-10-01Clinical Trial Update: Fipamezole in Neurogenic Orthostatic Hypotension [Phase 2]
Phase 2 clinical trial update on fipamezole for symptomatic neurogenic orthostatic hypotension, with associated conditions including Parkins…
-
FDA approval · 2008-09-26FDA Approved: CARBIDOPA, LEVODOPA, AND ENTACAPONE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for carbidopa, levodopa, and entacapone, submitted by Sandoz Inc.
-
FDA approval · 2008-09-18FDA Approved: CARBIDOPA AND LEVODOPA — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original application for a generic carbidopa-levodopa product from Rising Pharma Holdings, Inc. This product is used for th…
-
CLINICAL_TRIALS trial_result · 2008-09-18Clinical Trial Update: Weight Changes in Parkinsonian Patients, Treated With Deep Brain Stimulation [NA]
This completed clinical trial evaluated weight changes in Parkinson Disease patients treated with deep brain stimulation.
-
EMA guidance · 2008-09-04EMEA releases guidelines on development of medicines for Alzheimer's disease and Parkinson's disease
The EMA releases guidelines to guide development of medicines for Alzheimer's disease and Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2008-09-03Clinical Trial Update: Efficiency of Physiotherapeutic Care in Parkinson's Disease [Phase 3]
Phase 3 trial assessing the effectiveness of physiotherapeutic care in Parkinson's disease has completed. Detailed results are not provided …
-
FDA approval · 2008-08-29FDA Approved: CARBIDOPA, LEVODOPA, AND ENTACAPONE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for the Parkinson's disease combination therapy Carbidopa/Levodopa/Entacapone manufactured by Sandoz…
-
CLINICAL_TRIALS trial_result · 2008-08-29Clinical Trial Update: SLV308 for Treatment of Patients With Early Parkinson's Disease [Phase 3]
Phase 3 trial of SLV308 for early Parkinson's disease has completed.
-
CLINICAL_TRIALS research · 2008-08-20Clinical Trial Update: Automatic Recognition of Freezing of Gait Episodes
An ongoing clinical trial from Tel-Aviv Sourasky Medical Center investigates automatic recognition of freezing of gait episodes in Parkinson…
-
CLINICAL_TRIALS trial_result · 2008-08-14Clinical Trial Update: A Multiple-Dose Study of Sinemet® CR (Carbidopa/Levodopa) in Healthy Subjects
A multiple-dose Phase 1 study of Sinemet CR (carbidopa/levodopa) in healthy subjects to evaluate pharmacokinetics and safety; the trial has …
-
FDA approval · 2008-07-30FDA Approved: BROMOCRIPTINE MESYLATE — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approved Zydus Pharmaceuticals USA Inc.'s generic bromocriptine mesylate product under an Original Application (ANDA). Bromocriptine mes…
-
CLINICAL_TRIALS research · 2008-07-16Clinical Trial Update: Bio-Feedback to Improving Stability in Elderly Population [NA]
Update on a clinical trial evaluating bio-feedback to improve balance in elderly patients with Parkinson's disease; current status is unknow…
-
CLINICAL_TRIALS trial_result · 2008-06-16Clinical Trial Update: PET-Study: Effects of Single Doses of Stalevo and Levodopa/Carbidopa on Striatal 11C-Raclopride Binding [Phase 2]
Phase 2 clinical trial evaluating the effects of single doses of Stalevo and Levodopa/Carbidopa on striatal 11C-Raclopride binding in Parkin…
-
CLINICAL_TRIALS research · 2008-06-12Clinical Trial Update: The Effects of Rasagiline on Cognitive Deficits Associated With Parkinson's Disease [Phase 4]
Phase 4 clinical trial evaluating the effects of rasagiline on cognitive deficits in Parkinson's disease.
-
FDA approval · 2008-05-29FDA Approved: AMANTADINE HCL — Original Application (Bionpharma Inc.)
FDA approved AMANTADINE HCL as an Original Application generic product from Bionpharma Inc.
-
CLINICAL_TRIALS trial_result · 2008-05-23Clinical Trial Update: Adherence of Stalevo, Entacapone and Levodopa
A completed clinical trial evaluating adherence to Stalevo (carbidopa-levodopa-entacapone) and its components in individuals with Parkinson'…